Incorporated in 2004, the company is involved in the business of custom synthesis and manufacturing of specialty chemical intermediates involving complex and differentiated chemistry.
Paragon's Board okayed the 8th AGM notice & FY25-26 Director's Report. Key approvals include new auditor & scrutinizer appointments, related party transactions, and director re-appointments/regularizations, all subject to shareholder nod. Book closure date also set.